A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole

Clinical trial NCT04494243 · COMPLETED

Trial details

NCT number: NCT04494243
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2020-08-28
Primary completion: 2021-01-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.